|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/22/20 FSD Pharma Inc. 6-K 6/22/20 2:22K Newsfile Corp/FA |
Document/Exhibit Description Pages Size 1: 6-K Report by a Foreign Issuer -- form6k HTML 7K 2: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 12K
| FSD Pharma Inc.: Form 6-K - Filed by newsfilecorp.com |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2020
Commission File Number: 001-39152
FSD PHARMA INC.
(Translation of registrant's name into English)
520 William Street
Cobourg, Ontario
K9A 3A5
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
FSD Pharma Inc. |
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
Date: June 22, 2020 |
|
By: /s/ Donal Carroll |
|
|
|
Name: Donal Carroll |
|
|
|
Title: Chief Financial Officer |
|
|
|
|
| Exhibit | Description | |
| 99.1 | News Release dated June 22, 2020 |
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 6/22/20 | None on these Dates | ||
| List all Filings | ||||